Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
Latest Publications

TOTAL DOCUMENTS

26

(FIVE YEARS 0)

H-INDEX

3

(FIVE YEARS 0)

Published By Springer Vienna

9783709176603, 9783709176580

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

rHuEPO in surgical oncology

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_19 ◽

2002 ◽

pp. 325-346 ◽

Author(s):

Francesco Mercuriali ◽

G. Inghilleri

Keyword(s):

Surgical Oncology

Download Full-text

rhEPO in anemia associated with solid tumors and chemotherapy

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_14 ◽

2002 ◽

pp. 241-262 ◽

Author(s):

M. R. Nowrousian

Keyword(s):

Download Full-text

Predictive factors for response of anemia to recombinant human erythropoietin

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_15 ◽

2002 ◽

pp. 263-286 ◽

Author(s):

Yves Beguin

Keyword(s):

Predictive Factors ◽

Recombinant Human Erythropoietin ◽

Human Erythropoietin

Download Full-text

rhEPO in hematopoietic stem cell mobilization, transplantation and in-vitro expansion

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_16 ◽

2002 ◽

pp. 287-299

Author(s):

Sven Klaesson

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Mobilization ◽

Hematopoietic Stem ◽

In Vitro Expansion ◽

Hematopoietic Stem Cell Mobilization ◽

Cell Mobilization

Download Full-text

Cost-effectiveness of rHu-EPO in oncology

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_25 ◽

2002 ◽

pp. 435-446

Author(s):

Pierre-Y. Cremieux ◽

E. Dial ◽

M. Gustafson ◽

B. Sarokhan ◽

M. B. Slavin

Keyword(s):

Cost Effectiveness

Download Full-text

Relationship between anemia and tumor hypoxia

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_6 ◽

2002 ◽

pp. 117-125 ◽

Author(s):

Jürgen Dunst ◽

M. Molls

Keyword(s):

Download Full-text

Pathophysiology of cancer-related anemia

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_3 ◽

2002 ◽

pp. 39-62 ◽

Author(s):

M. R. Nowrousian

Keyword(s):

Cancer Related Anemia

Download Full-text

Protection of metabolic and exercise capacity following treatment with recombinant erythropoietin

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_22 ◽

2002 ◽

pp. 391-404 ◽

Author(s):

Kent Lundholm ◽

P. Daneryd

Keyword(s):

Exercise Capacity ◽

Recombinant Erythropoietin

Download Full-text

Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_20 ◽

2002 ◽

pp. 347-368 ◽

Author(s):

Lawrence T. Goodnough

Keyword(s):

Iron Metabolism ◽

Iron Supplementation

Download Full-text

Relationship between anemia, fatigue, and quality of life in cancer patients

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology ◽

10.1007/978-3-7091-7658-0_9 ◽

2002 ◽

pp. 173-184 ◽

Author(s):

Yvonne Brandberg

Keyword(s):

Quality Of Life ◽

Cancer Patients

Download Full-text